“This funding will allow us to further optimize our annotation and image analysis workflows, bringing the benefits to both new and existing customers,” Slide Score’s CEO Jan Hudecek explained.
Marius Wellenstein, CEO of WSK Medical: “We are excited to enable further adoption of Artificial Intelligence solutions to enhance analysis of cancerous tumours and connect each component in the pathology workflow into a fully integrated and comprehensive solution. We are thrilled to be able to do this with a great company like Slide Score.”
WSK Medical B.V.
WSK Medical develops Artificial Intelligence supported diagnostic tools to assist in the early detection of cancerous tumours. Our aim is to bring you the most advanced Artificial Intelligence technologies to assist Clinicians and Doctors. We do this by working in partnership, to develop sophisticated image recognition systems. For more information about our AI solutions, please contact us.
Slide Score B.V.
Slide Score is a web-based histopathology image management platform developed with the Netherlands Cancer Institute to help pathologists view, share and gather data from microscopy slides. To learn more, please visit www.slidescore.com.
Do you want to learn more about the capabilities of the new system? Contact us!